<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01472328</url>
  </required_header>
  <id_info>
    <org_study_id>ROS Paradoxon</org_study_id>
    <nct_id>NCT01472328</nct_id>
  </id_info>
  <brief_title>Effects of HBO Therapy on Muscular Insulin Resistence in Type 2 Diabetes</brief_title>
  <official_title>Effects of HBO Therapy on Muscular Insulin Resistence in Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>German Diabetes Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Heinrich-Heine University, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>German Diabetes Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hyperbaric oxygen therapy (HBO) is applied for several diseases. The effect on insulin
      sensitivity is yet unknown. Hypothesis: HBO therapy improves insulin sensitivity in patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      HBO therapy is applied to improve wound healing in diabetic patients with foot ulcera.
      However, it might induce oxidative stress as well as improve antioxidative capacity. The
      effects on insulin sensitivity in humans and will be tested in the study.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Skeletal muscle insulin sensitivity</measure>
    <time_frame>2 years</time_frame>
    <description>Determination of the influence of 2 hours hyperoxygenation on insulin sensitivity redox balance and lipid metabolites of skeletal muscle in patients with T2DM</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Obesity</condition>
  <condition>Non-insulin-dependent Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Hyperbaric oxygen therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Effect of 2 hrs HBO therapy on muscular insulin sensitivity and resistance in obesity and type 2 diabetes mellitus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyperbaric room air</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Effect of 2 hrs hyperbaric room air herapy on muscular insulin sensitivity and resistance in obesity and type 2 diabetes mellitus</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>HBO therapy</intervention_name>
    <description>Effect of 2 hrs HBO therapy on muscular insulin sensitivity and resistance in obesity and type 2 diabetes mellitus</description>
    <arm_group_label>Hyperbaric oxygen therapy</arm_group_label>
    <other_name>oxidative stress</other_name>
    <other_name>antioxidative capacity</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hyperbaric room air</intervention_name>
    <description>Effect of 2 hrs hyperbaric room air on muscular insulin sensitivity and resistance in obesity and type 2 diabetes mellitus</description>
    <arm_group_label>Hyperbaric room air</arm_group_label>
    <other_name>HBO therapy</other_name>
    <other_name>oxidative stress</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged ≥ 30 years- ≤ 70 years

          -  Balanced sex (50: 50)

          -  BMI 20- 25 kg/m 2 normal- weight group

          -  BMI 35- 39,9 kg/m 2 (Obese typ II)

        Exclusion Criteria:

          -  Acute illness 2 weeks before start of examination

          -  Autoimmune or Immune disorder deseases (Leukozyten &lt; 5000/µl

          -  Renal insufficiency (Kreatin &gt; 1,5 mg/dl)

          -  Heart disease, condition after heart attack

          -  Anemia (Hb &lt;12g/l, contolled before every day of eximination) or blood donations
             4weeks before eximinatin.

          -  Participation in another trial within the last 2 weeks

          -  Pharmacological- immuno therapy (Cortisol, Antihistaminika, ASS)

          -  Thyroid disorders

          -  Glitazone or Insulin- Therapy

          -  Pragnancy, Lactation, Menstruation

          -  Smoking cigaretts, Alcohol- and drug abuse

          -  Psychiatric disorders

          -  Risk for/ or diagnosed HIV/ AIDS or Hepatitis B/C

          -  Liver disease, which are not caused by non- alcoholic steato- hepatitis

          -  Working on night shifts or irregular rhythem of night- day

          -  Impaired wound healing or clotting disorders

          -  Allergic reaction to local anesthetics

          -  Malignant cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julia Szendrödi, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>German Diabetes Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julia Szendrödi, MD, PhD</last_name>
    <phone>0049 0211 3382 203</phone>
    <email>julia.szendrödi@ddz.uni-duesseldorf.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Deutsches Diabetes Zentrum</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julia Szendrödi, MD, PhD</last_name>
      <phone>0049 0211 3382 203</phone>
      <email>julia.szendrödi@ddz.uni-duesseldorf.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://ddz.uni-duesseldorf.de/index.html</url>
    <description>Homepage</description>
  </link>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 13, 2011</study_first_submitted>
  <study_first_submitted_qc>November 15, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 16, 2011</study_first_posted>
  <last_update_submitted>November 20, 2011</last_update_submitted>
  <last_update_submitted_qc>November 20, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 22, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>German Diabetes Center</investigator_affiliation>
    <investigator_full_name>julia szendrödi</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Oxidative stress</keyword>
  <keyword>Insulin resistance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

